Precigen to host r&d update virtual event on november 4th to share clinical developments

Germantown, md., oct. 27, 2021 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that the company will host a virtual event on thursday, november 4, 2021 at 11:00 am et to provide an update on the progress for its clinical pipeline.
PGEN Ratings Summary
PGEN Quant Ranking